TOP STORIES

• REGULATORY Council Approves Economic Revitalization Strategy with Priority on 3 Sectors Including Life Science
  August 1, 2012

• BUSINESS Sanofi-aventis Reaches Settlement with Sawai, Takata Seiyaku in Allegra Patent Dispute; Allegra’s Use Patent Validity Established
  July 31, 2012

• REGULATORY MHLW to Use Senshin-iryo System to Develop Anticancer Drugs from FY2013
  July 30, 2012

• BUSINESS DPP-4 Inhibitor “Indispensable” to Strengthen Priority Field: Kyowa Kirin
  July 30, 2012

• BUSINESS Chugai Had Tough Start in Final Year of Midterm Plan: Chairman Nagayama
  July 30, 2012

• BUSINESS Takeda Initiates PIII Trial for Anticancer Agent Motesanib in Asia
  July 27, 2012

• ORGANIZATION EFPIA Submits Opinion Letter to MHLW Calling for Review of Priority Focus on Japanese Companies for Blood Plasma Products
  July 27, 2012

• BUSINESS Taiho Licenses Anti-Allergy Drug from Faes Farma in Japan
  July 26, 2012

• REGULATORY MHLW Asks Sanofi Pasteur to Consider Reducing Price of IPV
  July 25, 2012

• ORGANIZATION Hiroshima Wholesale FTC Sees “Gradual Effects” in Correcting Labor Services in Cooperation with Pharmacists
  July 25, 2012

• BUSINESS Confident of Posting Sales of 100 Billion Yen with 3 Focal Products Including Teribone: Asahi Kasei Pharma President Asano
  July 24, 2012

• BUSINESS HBM Taking Advantage of Avian Biotechnology for Antibody Drug Discovery: President Toyoura
  July 23, 2012

• BUSINESS Inlyta as Standard Drug in Second-Line Treatment: Pfizer
  July 20, 2012

• REGULATORY Cost-Effective Assessments to Be Limited to Technologies for Which Alternatives Are Available: CSIMC
  July 19, 2012

• BUSINESS China to Overtake Japan as Second-Biggest Drug Market by 2016: IMS Health
  July 18, 2012

• ORGANIZATION 4.5 Bil. Yen Tax Hike Estimated in FY2012 Tax Reform: JPMA
  July 17, 2012

• BUSINESS RIJ Plans World’s First Trial of iPS Cell Therapy in Men: President & CEO Kagimoto
  July 16, 2012

• ORGANIZATION Wholesaler FTC to Make Serious Efforts for Improving “Services of Convenience”
  July 13, 2012

• BUSINESS Teijin Pharma to Boost New Drug Ratio to More than 50%, Prepare “Post-Feburic” Products: President Arao
  July 12, 2012

• BUSINESS Suzuken to Offer Voluntary Early Retirement Program for Record 500 Employees
  July 11, 2012

ページ

• « 先頭
• ‹ Prev
• …
• 229
• 230
• 231
• 232
• 233
• 234
• 235
• 236
• 237
• …
• Next ›
• 最終 »